Neuroacanthocytosis
Chorea
McLeod myopathy revisited: more neurogenic and less benign. (1/21)
The X-linked McLeod neuroacanthocytosis syndrome (MLS) has originally been denoted as 'benign' McLeod myopathy. We assessed the clinical findings and the muscle pathology in the eponymous index patient, Hugh McLeod, and in nine additional MLS patients. Only one patient had manifested with neuromuscular symptoms. During a mean follow-up of 15 years, however, eight patients including the initial index patient showed elevated skeletal muscle creatine kinase levels ranging from 300 to 3000 U/L, and had developed muscle weakness and atrophy. Two patients had disabling leg weakness. Muscle histology was abnormal in all 10 patients. Clear but unspecific myopathic changes were found in only four patients. All patients, however, had neurogenic changes of variable degree. Post-mortem motor and sensory nerve examinations support the view that muscle atrophy and weakness are predominantly due to an axonal motor neuropathy rather than to a primary myopathy. Multisystem manifestations developed in eight patients at a mean age of 39 years. Three patients manifested with psychiatric features comprising schizophrenia-like psychosis and personality disorder, two presented with generalized seizures and one with chorea. During follow-up, seven patients developed chorea, six had psychiatric disorders, five had cognitive decline and three had generalized seizures. Five patients died because of MLS-related complications including sudden cardiac death, chronic heart failure and pneumonia between 55 and 69 years. In conclusion, our findings confirm that MLS is not a benign condition but rather a progressive multisystem disorder sharing many features with Huntington's disease. (+info)Microembolization from an abdominal aortic aneurysm after thoracic aortic replacement. (2/21)
A 66-year-old man with thoracic and abdominal aortic aneurysm suffered from microembolism in the lower extremities after total arch replacement. He presented with livedo reticularis with palpable peripheral pulses, and the serum creatinine kinase level elevated up to 7,695. The abdominal aortic aneurysm, but not the thoracic aorta, was the origin of this complication. The morphological change of thrombus in the abdominal aorta detected by ultrasonography was the key to the diagnosis. Graft replacement of the abdominal aorta finally resolved his problem. (+info)Neuroacanthocytosis: a rare inherited movement disorder. (3/21)
The chorea-acanthocytosis syndrome (CHAC) is a rare disorder beginning in late adolescent or adult life in association with acanthocytosis, a normal lipid profile and characterized by progressive neurological disease. The inheritance is usually autosomal recessive, although apparent sporadic and autosomal dominant instances are also known. We report here a young man who presented with choreo-athetoid movement, dystonia, tics, symmetrical axonal polyneuropathy with normal cognitive function. The subsequent peripheral blood film reveals acanthocytes > 5%. Diagnosis of neuroacanthocytosis was made. (+info)Demonstration of cerebellar atrophy in neuroacanthocytosis of 2 siblings. (4/21)
(+info)The acanthocyte-echinocyte differential: The example of chorea-acanthocytosis. (5/21)
(+info)Bilateral temporal lobe epilepsy confirmed with intracranial EEG in chorea-acanthocytosis. (6/21)
(+info)Shape alterations in the striatum in chorea-acanthocytosis. (7/21)
(+info)Two McLeod patients with novel mutations in XK. (8/21)
(+info)Neuroacanthocytosis is a group of rare, genetic disorders characterized by the presence of abnormal red blood cells called acanthocytes, and various neurological symptoms. The neurological features typically include movement disorders such as chorea (involuntary, dance-like movements), dystonia (sustained muscle contractions causing twisting and repetitive movements or abnormal postures), and parkinsonism (symptoms similar to Parkinson's disease). Neuroacanthocytosis can also cause neuropsychiatric symptoms like personality changes, psychosis, dementia, and seizures.
There are two main types of neuroacanthocytosis: chorea-acanthocytosis (ChAc) and McLeod syndrome (MLS). ChAc is caused by mutations in the VPS13A gene, while MLS is due to mutations in the XK gene. Both conditions are inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disorder.
Diagnosis of neuroacanthocytosis typically involves blood tests to detect acanthocytes, genetic testing for VPS13A or XK gene mutations, and neurological evaluations to assess movement disorders and other neurological symptoms. Treatment is primarily focused on managing the specific symptoms of the disorder, as there is currently no cure for neuroacanthocytosis.
Acanthocytes are irregularly shaped red blood cells that have thorny or spiculated projections on their surface. These abnormal red blood cells are often seen in various medical conditions, including abetalipoproteinemia, malabsorption syndromes, liver diseases, and neuroacanthocytosis. The presence of acanthocytes can indicate abnormalities in lipid metabolism or membrane structure, which can lead to hemolysis and anemia. A blood film or smear is typically used to identify acanthocytes under a microscope.
Chorea is a medical term that describes an involuntary movement disorder characterized by brief, irregular, and abrupt jerky movements. These movements often occur randomly and can affect any part of the body. Chorea can also cause difficulty with coordination and balance, and can sometimes be accompanied by muscle weakness or rigidity.
The term "chorea" comes from the Greek word "χορεία" (khoréia), which means "dance," reflecting the graceful, dance-like movements that are characteristic of this condition. Chorea can occur as a symptom of various underlying medical conditions, including neurological disorders such as Huntington's disease, Sydenham's chorea, and cerebral palsy, as well as metabolic disorders, infections, and certain medications.
Treatment for chorea depends on the underlying cause of the condition and may include medications to help control the involuntary movements, physical therapy to improve coordination and balance, and lifestyle modifications to reduce the risk of injury from falls or other accidents. In some cases, surgery may be recommended as a last resort for severe or refractory chorea.